Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Government 59

Government Specialization Physicians Education 59

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Chem Commun 2014, 50, 9650‒9652. Org Process Res Dev 2022, 26, 9, 2685–2693. Sherwood J, De bruyn M, Constantinou A, et al.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Cadensee

JULY 26, 2021

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. When it comes to real marketing, usually we hire nutritionists and dietitians who are doing that work and really promoting the products with healthcare providers, mostly in the US. How do you are you dealing with competition in that market?

Retail 52

Retail Marketing Doctors Food 52

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. These actions allegedly led to the extension of Novartis’ patents. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.

Medical 98

Medical Manufacturing Insurance Side effects 98